RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      Non-compliance with recommended duration of zolpidem treatment and its predictors : analysis of 12-year Korean national health insurance database

      한글로보기

      https://www.riss.kr/link?id=T14741722

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Objective: Abuses of zolpidem have sporadically been reported and little is known regarding nationwide patterns of zolpidem use in Korea. This study investigates the extent of zolpidem usage exceeding the recommended duration and the predictors.
      Method: We conducted a drug utilization study using the national sample cohort database of the Korea National Health Insurance Corporation between 2002 and 2013. The study subjects were patients treated with zolpidem in the outpatient setting. An episode was defined as a period of continuous zolpidem therapy. The provider-based episode allowed for a gap of up to 3 days between two consecutive prescriptions from the same institution. The person-based episode allowed for a gap of up to 3 days, regardless of institution. We calculated the proportion of zolpidem use for periods over 30 days and conducted logistic regression analyses to investigate the relevant predictors. An adjusted odds ratio (aOR) with a 95% confidence interval (CI) was estimated for each predictor.
      Result: The usage of zolpidem is dramatically increased by approximately 18 times since zolpidem was authorized in the market (1,181 in 2002 vs. 21,399 in 2013). The treatment duration in 8.3% of episodes exceeded 30 days out of 75,087 zolpidem users. The odds of zolpidem prescription exceeding 30 days were highest in patients aged 65 years and older (aOR = 2.13, 95% CI: 1.78–2.53) and at tertiary hospitals (aOR = 2.14, 95% CI: 1.68–2.72). Women were more likely than men to be treated with zolpidem for over 30 days.
      Conclusion: We found dramatic increase of zolpidem use from 2002 to 2013. In 8.3% of the prescribed episodes of zolpidem, the recommended duration was exceeded. Efforts are required to reduce prescriptions that are inconsistent with the recommended guidelines for older patients, women, and in tertiary hospitals.
      번역하기

      Objective: Abuses of zolpidem have sporadically been reported and little is known regarding nationwide patterns of zolpidem use in Korea. This study investigates the extent of zolpidem usage exceeding the recommended duration and the predictors. Meth...

      Objective: Abuses of zolpidem have sporadically been reported and little is known regarding nationwide patterns of zolpidem use in Korea. This study investigates the extent of zolpidem usage exceeding the recommended duration and the predictors.
      Method: We conducted a drug utilization study using the national sample cohort database of the Korea National Health Insurance Corporation between 2002 and 2013. The study subjects were patients treated with zolpidem in the outpatient setting. An episode was defined as a period of continuous zolpidem therapy. The provider-based episode allowed for a gap of up to 3 days between two consecutive prescriptions from the same institution. The person-based episode allowed for a gap of up to 3 days, regardless of institution. We calculated the proportion of zolpidem use for periods over 30 days and conducted logistic regression analyses to investigate the relevant predictors. An adjusted odds ratio (aOR) with a 95% confidence interval (CI) was estimated for each predictor.
      Result: The usage of zolpidem is dramatically increased by approximately 18 times since zolpidem was authorized in the market (1,181 in 2002 vs. 21,399 in 2013). The treatment duration in 8.3% of episodes exceeded 30 days out of 75,087 zolpidem users. The odds of zolpidem prescription exceeding 30 days were highest in patients aged 65 years and older (aOR = 2.13, 95% CI: 1.78–2.53) and at tertiary hospitals (aOR = 2.14, 95% CI: 1.68–2.72). Women were more likely than men to be treated with zolpidem for over 30 days.
      Conclusion: We found dramatic increase of zolpidem use from 2002 to 2013. In 8.3% of the prescribed episodes of zolpidem, the recommended duration was exceeded. Efforts are required to reduce prescriptions that are inconsistent with the recommended guidelines for older patients, women, and in tertiary hospitals.

      더보기

      목차 (Table of Contents)

      • I. Background 1
      • 1. Introduction 1
      • II. Literature Review 3
      • 1. Definition of zolpidem 3
      • 2. Consideration for Guidelines of zolpidem 4
      • I. Background 1
      • 1. Introduction 1
      • II. Literature Review 3
      • 1. Definition of zolpidem 3
      • 2. Consideration for Guidelines of zolpidem 4
      • 3. Prescription pattern of zolpidem 5
      • 4. Perception of previous studies 6
      • III. Objective 7
      • IV. Method 8
      • 1. Data Source 8
      • 2. Data Selection 8
      • 3. Definition of Treatment Episode 11
      • 4. Maximum Duration of Zolpidem Treatment 15
      • 5. Statistical Analysis 15
      • V. Results 18
      • 1. Trends of Zolpidem Prescription 18
      • 2. Baseline characteristics of the Study Population 20
      • 3. Duration of Zolpidem Treatment 23
      • 4. Predictors of Zolpidem Prescription for Over 30 Days 30
      • VI. Discussion 37
      • VII. Conclusion 41
      • VIII. References 42
      • IX. Abstract in Korean 49
      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼